Research Stanford University Study Shows Improvements in Overall Survival for Follicular Grade 1-2 Lymphoma Patients from 1960-2003 A study recently published by Dr. Daryl Tan and colleagues from Stanford University shows encouraging…adminJuly 10, 2013
Press Releases In the fight against cancer, do Quebeckers stand the same chance? A promising new drug for the treatment of indolent non-Hodgkin Lymphoma (iNHL) has not had…adminJuly 3, 2013
Press Releases Lymphoma Canada Report Card uncovers the need for education and support in the Canadian lymphoma community. MISSISSAUGA, June 27, 2013 – Today, Lymphoma Canada releases its 2013 Lymphoma Report Card, revealing…adminJune 27, 2013
News Lymphoma Report Card 2013 One in 30 Canadians in their lifetime will be diagnosed with lymphoma, yet a large…adminJune 27, 2013
Research Ontario funds rituximab for the treatment of relapsed Chronic Lymphocytic Leukemia (CLL) Lymphoma Canada applauds the Ontario government for its decision to expand the funding criteria for…adminJune 10, 2013
Research Canadian Provinces Fund New Treatment for patients with indolent non-Hodgkin’s Lymphoma (iNHL) and Mantle Cell Lymphoma (MCL) Lymphoma Canada applauds the recent reimbursement announcements by the provinces of Alberta, Saskatchewan and Ontario…adminMay 29, 2013
News Healthy mind, body, and soul It is said time and time again. Diet and exercise is important. Studies suggest that…adminMay 8, 2013
News LC celebrates with a blast from the past Lymphoma Canada started the year off with a fundraiser at the Paul-Émile-Lépine Community Centre, where…adminMay 8, 2013
News One day dedicated to Information, help, and hope Be sure to mark September 15th on your calendars. That day is World Lymphoma Awareness…adminMay 8, 2013
News The High Price Tag of an Innovative Treatment The innovative drug ADCETRIS was approved for sale by Health Canada this past February. (more…)adminMay 8, 2013